Literature DB >> 22033914

[Prevention in chronic obstructive pulmonary disease. POET-COPD (prevention of exacerbations with tiotropium in COPD)].

A Gillissen1, S Nitschmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22033914     DOI： 10.1007/s00108-011-2964-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  14 in total

1.  [Recommendations for the choice of inhalatory systems for drug prescription].

Authors:  T Voshaar; E M App; D Berdel; R Buhl; J Fischer; T Gessler; P Haidl; J Heyder; D Köhler; M Kohlhäufl; C M Lehr; H Lindemann; H Matthys; T Meyer; H Olschewski; K D Paul; K Rabe; F Raschke; G Scheuch; T Schmehl; G Schultze-Werninghaus; D Ukena; H Worth
Journal:  Pneumologie       Date:  2001-12

2.  Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.

Authors:  Claus Vogelmeier; Peter Kardos; Sergio Harari; Steven J M Gans; Stephan Stenglein; Jackie Thirlwell
Journal:  Respir Med       Date:  2008-09-19       Impact factor: 3.415

3.  Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD.

Authors:  T Pera; A Zuidhof; J Valadas; M Smit; R G Schoemaker; R Gosens; H Maarsingh; J Zaagsma; H Meurs
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

4.  Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity.

Authors:  S Chodosh; J S Flanders; S Kesten; C W Serby; D Hochrainer; T J Witek
Journal:  J Aerosol Med       Date:  2001

5.  Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.

Authors:  James F Donohue; Charles Fogarty; Jan Lötvall; Donald A Mahler; Heinrich Worth; Arzu Yorgancioglu; Amir Iqbal; James Swales; Roger Owen; Mark Higgins; Benjamin Kramer
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

Review 6.  Is there a problem with inhaled long-acting beta-adrenergic agonists?

Authors:  Harold S Nelson
Journal:  J Allergy Clin Immunol       Date:  2006-01       Impact factor: 10.793

7.  Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro.

Authors:  Frank Bühling; Nadine Lieder; Ulrike C Kühlmann; Nadine Waldburg; Tobias Welte
Journal:  Respir Med       Date:  2007-08-29       Impact factor: 3.415

Review 8.  Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; Curt D Furberg
Journal:  JAMA       Date:  2008-09-24       Impact factor: 56.272

9.  Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial.

Authors:  D P Tashkin; B Celli; S Kesten; T Lystig; S Mehra; M Decramer
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

10.  Inhibition of granulocyte migration by tiotropium bromide.

Authors:  Gabriela Vacca; Winfried J Randerath; Adrian Gillissen
Journal:  Respir Res       Date:  2011-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.